Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors
Editat de Nima Rezaeien Limba Engleză Paperback – 14 dec 2021
The book is published as part of the three-volume Springer series Cancer Immunology, which aims to provide an up-to-date, clinically relevant review of cancer immunology and immunotherapy. Other volumes in the series address the translational medicine context and bench to bedside immunotherapy. Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors will be of special value to clinical immunologists, hematologists, and oncologists.
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (5) | 871.16 lei 38-45 zile | |
| Springer Berlin, Heidelberg – 22 aug 2016 | 1295.65 lei 3-5 săpt. | |
| Springer Berlin, Heidelberg – 5 oct 2016 | 871.16 lei 38-45 zile | |
| Springer International Publishing – 14 dec 2021 | 967.22 lei 38-45 zile | |
| Springer International Publishing – 27 sep 2021 | 976.34 lei 38-45 zile | |
| Springer International Publishing – 25 aug 2021 | 1001.67 lei 38-45 zile | |
| Hardback (2) | 1345.86 lei 38-45 zile | |
| Springer International Publishing – 13 dec 2020 | 1345.86 lei 38-45 zile | |
| Springer International Publishing – 29 ian 2020 | 1389.23 lei 38-45 zile |
Preț: 967.22 lei
Preț vechi: 1018.12 lei
-5% Nou
Puncte Express: 1451
Preț estimativ în valută:
185.17€ • 192.47$ • 153.52£
185.17€ • 192.47$ • 153.52£
Carte tipărită la comandă
Livrare economică 03-10 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783030579517
ISBN-10: 3030579514
Pagini: 581
Ilustrații: XXX, 581 p. 34 illus., 30 illus. in color.
Dimensiuni: 178 x 254 mm
Greutate: 1.4 kg
Ediția:2nd ed. 2020
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
ISBN-10: 3030579514
Pagini: 581
Ilustrații: XXX, 581 p. 34 illus., 30 illus. in color.
Dimensiuni: 178 x 254 mm
Greutate: 1.4 kg
Ediția:2nd ed. 2020
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
Cuprins
Specific Organ Tumors: General Considerations On Immunotherapy.- Vaccination Of Human Solid Tumors: Recent Progress In The Clinical Setting.- Immunotherapy For Pediatric Solid Tumors.- Immunopathology Of Hematological Cancers And Immunotherapy Of Leukemia And Multiple Myeloma.- Immunopathology Of Lymphoma And Immunotherapy Of Hodgkin's Disease And Non-Hodgkin's Lymphoma.- Cancer-Testis Antigens As Targets For The Immunotherapy Of Hematological Malignancies.- Tumor Immunology And Immunotherapy Of Gastrointestinal Tract Cancers.- Immunology And Immunotherapy Of Colorectal Cancer.- Immunopathology Of Hepatobiliary Tumors And Immunotherapy Of Liver Cancers.- Immunology And Immunotherapy Of Pancreatic Tumors.- Immunology Of Cutaneous Tumors And Immunotherapy For Melanoma.- Immunopathology Of Head And Neck Tumors And Immunotherapy Of Squamous Cell Carcinoma.- Immunopathology And Immunotherapy Of Oral Cancers.- Immunopathology Of Bone And Connective Tissue Cancers And Immunotherapy Of Sarcomas.- Immunopathology Of Central Nervous System Cancers And Immunotherapy Of Brain Tumors.- Immunology And Immunotherapy Of Pulmonary Tumors.- Immunopathology Of Urinary System Cancers And Immunotherapy Of Renal And Bladder Cancers.- Immunopathology Of Cancers Of Male And Female Genitalia Organs And Immunotherapy Of Cervical And Prostate Cancer.- Immunology And Immunotherapy Of Ovarian Cancer.- Revisiting Immunology For Breast Cancer.- Immunology And Immunotherapy Of Graft Versus Host Disease.
Notă biografică
Nima Rezaei gained his medical degree from Tehran University of Medical Sciences in 2002 and subsequently obtained an MSc in Molecular and Genetic Medicine and a PhD in Clinical Immunology and Human Genetics from the University of Sheffield, UK. He also undertook a short-term fellowship of Clinical Immunology and Bone Marrow Transplantation in the Newcastle General Hospital. Since 2010, Dr. Rezaei has worked at the Department of Immunology, School of Medicine, Tehran University of Medical Sciences. He is now the Vice Dean of International Affairs, School of Medicine, Tehran University of Medical Sciences; Director of the Global Academic Program, Tehran University of Medical Sciences; and co-founder and Deputy President of the Research Center for Immunodeficiencies. He is also the Founding President of Universal Scientific Education and Research Network (USERN). Dr. Rezaei has already been the director of more than 50 research projects and has designed and participated in several international collaborative projects. He is an editorial assistant or board member for more than 30 international journals. He has edited more than 10 books, has presented more than 400 lectures/posters in congresses/meetings, and has published more than 600 articles in international scientific journals.
Textul de pe ultima copertă
This book explains the immunology of organ-specific malignancies and discusses novel immunotherapy strategies for their treatment. Since the first, very successful edition of the book was published in 2015, a number of entirely new chapters have been included. The range of cancers considered has accordingly been extended, with coverage of the latest immunotherapy approaches for skin cancers, ocular malignancies, endocrine malignancies, cardiac cancers, vascular cancers, and HPV-associated cancers. In addition, the original chapters have been updated to document the latest advances in immunotherapy for pediatric solid tumors, hematologic malignancies, gastrointestinal tumors, bone tumors, CNS tumors, lung cancer, genitourinary tract tumors, and breast cancer, among others.
The book is published as part of the three-volume Springer series Cancer Immunology, which aims to provide an up-to-date, clinically relevant review of cancer immunology and immunotherapy. Other volumes in the series address the translational medicine context and bench to bedside immunotherapy. Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors will be of special value to clinical immunologists, hematologists, and oncologists.
The book is published as part of the three-volume Springer series Cancer Immunology, which aims to provide an up-to-date, clinically relevant review of cancer immunology and immunotherapy. Other volumes in the series address the translational medicine context and bench to bedside immunotherapy. Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors will be of special value to clinical immunologists, hematologists, and oncologists.
Caracteristici
Explains the immunology of organ-specific tumors
Discusses novel immunotherapy strategies for treatment of each of these malignancies
Updated and revised edition featuring additional chapters on malignancies not previously covered
Discusses novel immunotherapy strategies for treatment of each of these malignancies
Updated and revised edition featuring additional chapters on malignancies not previously covered
Recenzii
“This book will provide up to date information about various aspects of tumor immunology. It will be useful to both clinical and experimental oncologists. Accordingly this book should be available through libraries in printed or on-line version for all in need for excellently collected survey of information about tumor immunology.” (Katarina Polakova, Neoplasma, Issue 3, 2015)